Sotera Health Company (MUN:SH5)

Market Cap	4.22B +12.1%
Revenue (ttm)	980.47M +2.7%
Net Income	47.23M -21.7%
EPS	0.17 -21.7%
Shares Out	n/a
PE Ratio	89.30
Forward PE	18.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	8
Open	14.80
Previous Close	14.80
Day's Range	14.70 - 14.80
52-Week Range	8.60 - 16.70
Beta	n/a
RSI	46.32
Earnings Date	Feb 24, 2026

About Sotera Health Company

Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets. The Nordion segment pr...

• Industry: Testing Laboratories
• Founded: 2015
• Employees: 3,000
• Stock Exchange: Munich Stock Exchange
• Ticker Symbol: SH5

Financial Performance

In 2024, Sotera Health Company's revenue was $1.10 billion, an increase of 4.88% compared to the previous year's $1.05 billion. Earnings were $44.34 million, a decrease of -13.21%.

Financial numbers in USD